Mmr vaccine - PowerPoint PPT Presentation


Malaria Vaccines 101

Explore the complexities of malaria vaccine development, targeting Plasmodium species/stages, immunity evidence, and broad vaccine approaches focusing on sub-unit vaccines. Discover the quest for an effective and accessible malaria vaccine.

9 views • 32 slides


Urgent Measles Awareness Campaign in Response to Rising Cases in England

Measles cases are on the rise in England, with a significant number reported in London. The vaccination rate is below the target set by WHO, posing a high risk of outbreaks. The campaign aims to increase awareness about the seriousness of measles, educate the public on the benefits of the MMR vaccin

0 views • 14 slides



GP Practice Action Check List for National MMR Catch-up Call and Recall - January 2024

Measles, mumps, and rubella are infectious diseases with serious consequences. The MMR vaccine is crucial for protection. As MMR vaccine coverage declines, there is a National MMR Call and Recall initiative in February and March 2024. General practices are advised to prepare for patient enquiries, c

3 views • 4 slides


Addressing Health Inequalities and Vaccine Hesitancy in Shirebrook: Findings and Strategies

Shirebrook, a deprived area in Derbyshire, has been grappling with health inequalities and vaccine hesitancy, particularly among certain groups like ethnic minorities and those living in deprivation. Efforts have been made to engage the community, resulting in varying levels of vaccine uptake among

1 views • 14 slides


Update on Infectious Disease Prevention and H5N1 Vaccine Production

This content provides updates on infectious disease prevention efforts, including historical data, TB data posting schedule, and HIV surveillance updates. It also highlights the plans of the US Department of Health and Human Services to produce 4.8 million doses of the H5N1 avian flu vaccine for pan

0 views • 7 slides


Making Informed Vaccine Decisions for Your 2-Month-Old Infant

Congratulations on your infant reaching 2 months! Learn about the importance of vaccines and how to make informed decisions regarding vaccinating your baby. Access valuable resources from CDC to understand vaccine benefits and risks. Still unsure? Get familiar with vaccine-preventable diseases and h

0 views • 14 slides


Understanding Polio Eradication Efforts and Vaccine Development

Polio, a disabling disease caused by the poliovirus, mainly affects children and can lead to paralysis. Efforts to eradicate polio include the development of vaccines like the Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). The poliovirus' choice of host, ease of transmission, and impa

0 views • 15 slides


Moderna Becomes Third Covid Vaccine Approved in the UK - Important Updates

The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains

0 views • 7 slides


National COVID-19 Vaccine Deployment and Roll-Out Plan in Zimbabwe

The Republic of Zimbabwe is gearing up for the introduction of a COVID-19 vaccine as part of its response to the pandemic, with a focus on deploying 200,000 doses to priority groups. The comprehensive plan includes key strategies, financing alignment, and integration into national governance mechani

5 views • 28 slides


Immunization Requirements for New BSN Students

Required immunization documentation, including Hepatitis B, MMR, Tetanus, Varicella, and Influenza, must be submitted before enrolling in Nursing classes. A titer is a blood test measuring immunity to diseases. Details on Hepatitis B vaccination series, MMR requirements, and non-responder status are

0 views • 13 slides


BCG Vaccine: Overview, Administration, and Considerations

BCG vaccine, a live attenuated vaccine, protects against tuberculosis with varying efficacy. It is administered intradermally in the left upper arm, leaving a characteristic scar. Adverse reactions are generally mild, but contraindicated in immunodeficiency or HIV infection.

0 views • 12 slides


Understanding Vaccine Safety, Effectiveness, and Side Effects: A Guide to Better Living

This informative content delves into vaccine safety, effectiveness, and side effects, offering insights into the development stages of vaccines, COVID-19 vaccine comparisons, and an overview of COVID-19 vaccine development. It also explains how vaccines work to protect against viruses and emphasizes

0 views • 33 slides


Installation Guide for VFC-400 Vaccine Monitoring Data Logger Kit

This installation guide provides step-by-step instructions for installing the probe of the VFC-400 Vaccine Monitoring Data Logger Kit in a fridge or freezer. The guide includes details on placing the probe, routing the cable, securing with zip ties, and mounting the logger for efficient monitoring.

0 views • 5 slides


VFC-400 Vaccine Monitoring Data Logger Kit Operations Overview

This presentation provides a detailed guide on operating the VFC-400 Vaccine Monitoring Data Logger Kit. It covers essential functions like entering review mode, starting and stopping recording, and monitoring temperature data. The step-by-step instructions ensure accurate temperature logging for va

0 views • 9 slides


Potential Pyogenic Liver Abscess Case Report in Elderly Female Post COVID-19 Vaccination

An 84-year-old female presented with fever, SOB, fatigue, and diarrhea after receiving a COVID-19 vaccine. Despite initial improvement with antibiotics, she developed liver abscess, highlighting the complexity of diagnosing post-vaccination symptoms. Clinicians should remain vigilant and consider al

0 views • 5 slides


COVID-19 Vaccine Update: Pfizer Vaccine Logistics and Emergency Use Authorization

The update discusses the latest information on Pfizer's COVID-19 vaccine, including details on the new technology, storage requirements, logistics handling, and Emergency Use Authorization (EUA). Pfizer's vaccine, with a 95% efficacy rate, requires storage in ultra-low-temperature freezers or therma

0 views • 28 slides


Co-created Messages & Trusted Messengers for COVID-19 Vaccine Acceptance in Northern Nigeria

Dr. Chizoba Wonodi is evaluating the use of co-created messages and trusted messengers to improve COVID-19 vaccine acceptance in Northern Nigeria. Vaccine hesitancy due to conspiracy theories and safety concerns remains a challenge. TM-COVAC study aims to design targeted messages using human-centere

0 views • 8 slides


VASE+ Release 11.4: New Features for Vaccine Management

In the latest VASE+ Release 11.4, several new features have been introduced to enhance vaccine management processes. These include a new vaccine selection field, Pfizer vaccine lot addition for 5-11-year-olds, color coding per vaccine type, customizability options, new columns for vaccine name and s

0 views • 8 slides


Vaccine Administration Best Practices and Waste Management

This content provides valuable information on handling vaccines, including determining vaccine viability, identifying wastage, and understanding expiration dates. It includes scenarios covering vaccine storage, reporting spoiled doses, and managing vial wastage. The answers and explanations offered

0 views • 7 slides


Understanding the Impact of Vaccine Wastage on Measles Elimination Efforts

This presentation focuses on the significance of vaccine wastage in the context of measles elimination, emphasizing the factors influencing wastage, why it matters for achieving high vaccination coverage, and tools for estimating wastage. The content highlights the challenges posed by wastage on vac

0 views • 13 slides


Interrogating the Establishment of Vaccine Plants in Africa: Case Studies of Rwanda and Uganda

Nimrod Muhumuza, from Afya na Haki Institute, presents a critical analysis of vaccine plant setup in Rwanda and Uganda. The discussion focuses on the potential leadership roles of small economies, private sector involvement, sustainability of vaccine production, and the importance of participation f

0 views • 13 slides


Effect of Efgartigimod on Humoral Vaccine Responses in Patients with Autoimmune Diseases

The study explores the impact of Efgartigimod, a Neonatal Fc Receptor blocker, on humoral vaccine responses in patients with autoimmune diseases. It discusses how immunosuppressive therapies used in autoimmune disorders may affect susceptibility to infections and impair vaccine immunogenicity, highl

0 views • 18 slides


National MMR Call and Recall Support Checklist for General Practices

Measles, mumps, and rubella are infectious diseases that can be prevented with the MMR vaccine. The UK is conducting a national MMR call and recall initiative to increase vaccination coverage, especially targeting 6-11-year-olds. General practices are advised to prepare for patient inquiries, check

0 views • 4 slides


Understanding the COVID-19 Vaccine: Information from Illinois Department of Corrections

The Illinois Department of Corrections emphasizes the importance of the COVID-19 vaccine, highlighting its effectiveness in preventing severe illness. Individuals are encouraged to make an informed decision about vaccination, ensuring protection for themselves and others. The department assures that

0 views • 52 slides


Understanding the Oxford-AstraZeneca Vaccine: Benefits, Risks, and Recommendations

The Oxford-AstraZeneca vaccine has shown a likely but unproven link to cerebral venous sinus thrombus and other blood clotting issues. Despite this, the benefits of vaccination still outweigh the risks, with only approximately 4 cases per million resulting in death. Communication of the potential be

0 views • 10 slides


Key Findings and Recommendations from VET Evaluation July 2022

A presentation of key findings and recommendations from the Vaccine Engagement Teams (VETs) Evaluation in July 2022, highlighting increased vaccine confidence, effective ambassador outreach, and innovative community health programming. The evaluation assessed the VETs' achievements, identified barri

0 views • 19 slides


Update on COVID-19 Vaccine Uptake in Tennessee as of October 8, 2021

In this update, Tennessee reports an increase in COVID-19 vaccine uptake with 52.8% having at least one dose and 46.7% fully immunized. The state ranks 40th in vaccine administration per 100K population. Vaccine hesitancy is addressed, and dates of FDA committee meetings on booster authorizations an

0 views • 15 slides


History of Vaccine Liability and Legal Issues in the United States

This presentation discusses the history of vaccine liability and legal battles in the United States, covering events such as the Cutter Incident, the Swine Flu vaccine campaign, and cases like Berkovitz v. U.S. It explores the challenges, consequences, and legal defenses surrounding vaccine-related

0 views • 25 slides


Addressing the Measles Outbreak: UKHSA's Response and National Campaign Launch

Measles cases are rising in England, particularly in London, with a concerning low vaccination rate. UKHSA predicts high risk in London and nationwide, urging for intervention to prevent further spread. A national campaign focusing on MMR vaccine uptake is set to launch on 14th July, targeting low u

0 views • 10 slides


Michigan COVID-19 Vaccine Survey Insights

The Michigan COVID-19 Survey conducted in March 2021 provides valuable insights on vaccine segments, key findings, and likelihood to get the vaccine among residents aged 16 and older. The survey categorizes individuals into Vaccine Definites, Persuadables, and Nevers, highlighting that 61% are firml

1 views • 10 slides


Reproductive and Child Health Programme Overview

The Reproductive and Child Health Programme has a rich historical background dating back to 1952, with the aim of promoting the health of mothers and children, reducing infant and maternal mortality rates, and achieving population stabilization. The programme focuses on various interventions and str

0 views • 30 slides


Vaccine Inventory Lot Management Job Aid

This job aid explains how Site Admins can add, edit, and manage vaccine inventory lots for clinics. Users can add new vaccine lots, edit existing entries, and associate vaccine lots with specific clinics in the system. The process involves entering lot details, NDC code, expiration, and available do

0 views • 4 slides


Global Vaccine and Immunization Research Forum 2023 Agenda

The Global Vaccine and Immunization Research Forum 2023, scheduled for March 28-30 at Grand Hyatt, Incheon, Korea, will feature keynote speakers, plenary sessions, workshops, and discussions on various topics related to vaccine research, development, and global health. The agenda includes sessions o

0 views • 9 slides


COVID-19 Vaccination for People Experiencing Homelessness Presentation Overview

This presentation, developed by CDC's COVID-19 Response Vaccine Task Force and Homelessness Unit, focuses on COVID-19 vaccination basics, safety, prioritization for individuals experiencing homelessness, and strategies to overcome barriers to vaccination. It highlights the importance of understandin

0 views • 49 slides


COVID-19 Vaccine Updates and Recommendations - January 2023

New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi

0 views • 6 slides


NC COVID-19 Vaccine Plan Update Oct 9, 2020 Task Force Meeting Overview

The NC COVID-19 Vaccine Plan discussed in the October 9, 2020 Task Force Meeting includes details on vaccine supply, distribution goals, clinical trial timelines, safety, and outreach strategies. Key points cover vaccine development progress, trial protocols, distribution targets, and communication

0 views • 6 slides


Safety and Efficacy of BNT162b2 mRNA Covid-19 Vaccine Phase 3 Data

Phase 3 data of the BNT162b2 mRNA Covid-19 vaccine, including study design, participant groups, primary endpoints, and key findings regarding safety and efficacy. The vaccine demonstrated efficacy against confirmed Covid-19, with reported local and systemic adverse effects within a specified timefra

0 views • 48 slides


Aging and Disability Vaccine Collaborative (ADVC) Project Overview

The Aging and Disability Vaccine Collaborative (ADVC) led by Tannis Hargrove at the University of Montana aims to support vaccination education and promotion activities for older adults and people with disabilities. Through partnerships with various organizations, the ADVC provides accessible and in

0 views • 12 slides


Introduction of Gardasil HPV Vaccine in Sikkim's Routine Immunization Programme

Cervical cancer is a major health issue in Sikkim, India, prompting the introduction of the Gardasil HPV vaccine to address the high prevalence of HPV infections leading to cervical cancer. The state-wide immunization campaign targeted girls aged 9-14, aiming to incorporate the vaccine into the rout

0 views • 10 slides


Permutation Tests and False Detection Rate in HPV Vaccine Trial

Permutation tests are computer-intensive methods used for hypothesis testing when the distribution of the test statistic is unknown. In a hypothetical HPV vaccine trial with 200 women, the scientific question revolves around comparing infection risks in groups receiving the vaccine and placebo. The

0 views • 19 slides